10 Interstitial Cystitis Clinical Trials in Scottsdale, AZ (2026)

Q: How do I join a clinical trial in Scottsdale?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Scottsdale research site will contact you.

Recruiting Interstitial Cystitis Studies in Scottsdale

NCT06628908Recruiting

Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy

The purpose of this study is to evaluate the efficacy, safety, and tolerability of Suzetrigine (SUZ) in participants with pain associated with diabetic peripheral neuropathy (DPN)....

Scottsdale, AZPHASE31,100 participantsVertex Pharmaceuticals Incorporated

View Study Details

NCT03492151Recruiting

Confocal Laser Endomicroscopy as an Imaging Biomarker for the Diagnosis of Pancreatic Cystic Lesions

The study schema is shown in Figure 4. (A) All patients referred to one of the participating academic centers for EUS evaluation of the PCL will be enrolled in the protocol if they satisfy inclusion c...

Scottsdale, AZ500 participantsOhio State University Comprehensive Cancer Center

View Study Details

NCT07532603Recruiting

A Phase 2/3 Study of Brepocitinib in Adults With Lichen Planopilaris

This study will evaluate the clinical safety and efficacy of oral brepocitinib in participants with lichen planopilaris...

Scottsdale, AZPHASE2342 participantsPriovant Therapeutics, Inc.

View Study Details

NCT07449923Recruiting

CAPRI: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME

This is a phase 3 randomized, double -masked study comparing the efficacy of EYP-1901 against Aflibercept....

Scottsdale, AZPHASE3240 participantsEyePoint Pharmaceuticals, Inc.

View Study Details

NCT06576271Recruiting

A Study of GSK4527363 in Healthy Participants, Systemic Lupus Erythematosus (SLE) Participants, Healthy Chinese, and Japanese Participants and CTD-ILD Participants

This study will assess the safety, tolerability, pharmacokinetics, pharmacodynamics and immunogenicity of GSK4527363 in healthy participants (Part A), participants with active SLE (Part B), healthy pa...

Scottsdale, AZPHASE1142 participantsGlaxoSmithKline

View Study Details

NCT06635980Recruiting

Hypofractionated Radiotherapy Before or After Breast Surgery for Treatment of Patients With Non-Metastatic Breast Cancer

This phase II trial studies how well hypofractionated radiotherapy before (preoperative) or after (postoperative) breast surgery works in treating patients with different types of non-metastatic (has ...

Scottsdale, AZPHASE2120 participantsMayo Clinic

View Study Details

NCT07142291Recruiting

PHENOGENE-1A (Cromolyn) Treatment in Patients With Mild to Moderate ALS

The purpose of this study is to test the effects of PHENOGENE-1A, which is the treatment under investigation in this study. This research will investigate if PHENOGENE-1A can help people with ALS by m...

Scottsdale, AZPHASE2105 participantsPhenoNet, Inc.

View Study Details

NCT06975306Recruiting

Radiographic Findings and Clinical Outcomes After Bone Grafting Patellar Defect in ACL Reconstruction

All patients will be randomly assigned using a computer randomization algorithm to one of two matched cohort groups. Patients will not be advised which group they belong to until after the completion ...

Scottsdale, AZNA75 participantsUniversity of Arizona

View Study Details

NCT07136181Recruiting

Evaluation of the Safety, Efficacy, and Pharmacokinetics of NBM-BMX in Patients With Metastatic Uveal Melanoma

This study is being done to find the best dose of an investigational drug called NBM-BMX for people with metastatic uveal melanoma, a type of eye cancer that has spread to other parts of the body. Th...

Scottsdale, AZPHASE136 participantsNovelwise Pharmaceutical Corporation

View Study Details

NCT06525766Recruiting

Adaptive Therapy With Capecitabine for Treatment of Metastatic ER Positive, HER2 Negative Breast Cancer

This phase II trial evaluates the effect of capecitabine on tumor response using imaging and tumor markers to adjust dose (adaptive therapy) in patients with estrogen receptor (ER) positive, HER2 nega...

Scottsdale, AZPHASE235 participantsMayo Clinic

View Study Details

About Interstitial Cystitis Clinical Trials in Scottsdale

Interstitial cystitis/bladder pain syndrome is a chronic condition causing bladder pressure, bladder pain, and sometimes pelvic pain. It primarily affects women and can significantly impact quality of life. Treatment includes dietary changes, bladder instillations, oral medications, and neuromodulation.

There are currently 10 interstitial cystitis clinical trials recruiting participants in Scottsdale, AZ. These studies are seeking a combined 2,695 participants. Research is being sponsored by Vertex Pharmaceuticals Incorporated, Ohio State University Comprehensive Cancer Center, Priovant Therapeutics, Inc. and 6 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Interstitial Cystitis Clinical Trials in Scottsdale — FAQ

Are there interstitial cystitis clinical trials in Scottsdale?

Yes, there are 10 interstitial cystitis clinical trials currently recruiting in Scottsdale, AZ. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Scottsdale?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Scottsdale research site will contact you about next steps.

Are clinical trials in Scottsdale free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Scottsdale studies also compensate for your time and travel.

What interstitial cystitis treatments are being tested?

The 10 active trials in Scottsdale are testing new therapies including novel drugs, biologics, and treatment approaches for interstitial cystitis.

Data updated July 19, 2026 from ClinicalTrials.gov